MMDA-07 OVERALL SURVIVAL WITH IMMUNOTHERAPY PLUS STEREOTACTIC RADIOSURGERY VERSUS IMMUNOTHERAPY ALONE IN NSCLC BRAIN METASTASES: A META-ANALYSIS
Abstract Lung cancer remains the most common malignancy worldwide, with non-small cell lung cancer (NSCLC) accounting for approximately 80–85% of cases, predominantly adenocarcinoma and squamous cell carcinoma. Brain metastases (BMs) are a frequent and harmful complication, occurring in approximately 10% of patients at...